Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

1,459 trials

2024-514744-91-00
Recruiting
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ATX304
Phase 1 · Germany · 1 site
Registry update: 30 Jul 2026
NCT07742917
Recruiting
Precision Lifestyle Medicine Program for IFHAS Participants
Not applicable · United Arab Emirates · 1 site
Registry update: 3 Aug 2026
NCT07757087
Recruiting
A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity, Compared to a Low-calorie Diet or Placebo
Phase 1 · Denmark, Netherlands · 2 sites
Registry update: 1 Oct 2026
NCT07734311
Recruiting
A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)
Phase 3 · China · 1 site
Registry update: 31 Aug 2026
NCT07724522
Recruiting
Prebiotic Inulin for Late-Reproductive Individuals
Not applicable · United States · 1 site
Registry update: 11 Aug 2026
NCT07317310
Recruiting
The NTU JO-SMART Study
Not applicable · Taiwan · 2 sites
Registry update: 24 Jul 2026
NCT07619989
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists
Not applicable · China · 1 site
Registry update: 31 Jul 2026
NCT07698145
Recruiting
Changes in Body Composition Including Muscle With Anti-Obesity Medications, Both With and Without Exercise
Not applicable · United States · 1 site
Registry update: 15 Jul 2026
NCT07738614
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Phase 1 · Singapore, United States · 2 sites
Registry update: 20 Aug 2026
NCT07774065
Recruiting
Mechanical Ventilation in Obese Surgical Patients
Not applicable · United States · 1 site
Registry update: 19 Aug 2026
NCT07684144
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Phase 3 · Canada, United Kingdom, Japan, Puerto Rico, United States · 45 sites
Registry update: 5 Oct 2026
NCT07731139
Recruiting
A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity
Phase 1 · United States · 1 site
Registry update: 23 Sept 2026
NCT07685808
Recruiting
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Phase 2 · United States · 21 sites
Registry update: 6 Nov 2026
NCT07588438
Recruiting
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
Phase 4 · Paraguay · 1 site
Registry update: 19 May 2026
NCT07702890
Recruiting
A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D
Phase 1/2 · Germany · 1 site
Registry update: 10 Sept 2026
NCT07670884
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
Phase 3 · China · 2 sites
Registry update: 13 Aug 2026
NCT07684235
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Phase 3 · Australia, Canada, Japan, Puerto Rico, United States · 91 sites
Registry update: 5 Oct 2026
NCT07728669
Recruiting
Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
Not applicable · Kazakhstan · 1 site
Registry update: 11 Aug 2026
2025-524612-11-00
Recruiting
Effect on the tolerability of semaglutide in overweight adults without diabetes
Phase 4 · Estonia · 1 site
Registry update: 21 May 2026
NCT07654374
Recruiting
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Phase 3 · United States · 70 sites
Registry update: 20 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.